oseltamivir has been researched along with Recrudescence in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Mamishi, S; Navaeian, A; Shabanian, R | 1 |
Martins, J; Monteiro, A; Ribeiro, L | 1 |
Cahyadi, A; Henrina, J; Pusparani, A | 1 |
Kimura, F; Kobayashi, A; Kobayashi, S; Motoyoshi, K; Sato, K | 1 |
Amitai, Z; Grotto, I; Hindiyeh, M; Kaliner, E; Kopel, E; Mandelboim, M; Mendelson, E; Volovik, I | 1 |
Kim, IY; Kim, SR; Kwak, IS; Lee, DW; Lee, SB; Rhee, H; Seong, EY; Song, SH | 1 |
Ijichi, N; Ijichi, S | 1 |
Owen Hendley, J; Pappas, DE | 1 |
1 review(s) available for oseltamivir and Recrudescence
Article | Year |
---|---|
Otitis media. A scholarly review of the evidence.
Topics: Acetamides; Acute Disease; Age Factors; Amoxicillin; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Humans; Infant; Influenza Vaccines; Influenza, Human; Meta-Analysis as Topic; Oseltamivir; Otitis Media; Otitis Media with Effusion; Placebos; Pneumococcal Infections; Pneumococcal Vaccines; Randomized Controlled Trials as Topic; Recurrence; Streptococcus pneumoniae; Time Factors | 2003 |
7 other study(ies) available for oseltamivir and Recrudescence
Article | Year |
---|---|
Acute aortic dissection in a patient with Williams syndrome infected by COVID-19.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Aortic Aneurysm; Aortic Dissection; Aortic Stenosis, Supravalvular; Aortitis; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Fatal Outcome; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Male; Methylprednisolone; Oseltamivir; Recurrence; Ritonavir; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Williams Syndrome | 2021 |
Hyperacute relapse of Lewis-Sumner syndrome during influenza A (H1N1) virus infection.
Topics: Antiviral Agents; Chronic Disease; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Magnetic Resonance Imaging; Male; Middle Aged; Oseltamivir; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Recurrence; Syndrome | 2020 |
Co-infection of COVID-19 and recurrent malaria.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Humans; Indonesia; Malaria; Male; Oseltamivir; Recurrence; SARS-CoV-2; Young Adult | 2021 |
Influenza virus reactivation after remission with oseltamivir treatment in a patient undergoing nonmyeloablative bone marrow transplantation.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Hematopoietic Stem Cell Transplantation; Humans; Influenza A virus; Influenza, Human; Male; Oseltamivir; Recurrence; Transplantation Conditioning | 2008 |
Possible recurrent pandemic (H1N1) 2009 infection, Israel.
Topics: Adolescent; Antibodies, Viral; Antiviral Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Israel; Male; Neuraminidase; Oseltamivir; Pandemics; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Young Adult | 2010 |
Relapse of minimal change disease following infection with the 2009 pandemic influenza (H1N1) virus.
Topics: Antiviral Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney; Male; Nephrosis, Lipoid; Oseltamivir; Pandemics; Recurrence; Young Adult | 2012 |
Too early cure of influenza: recurrence in oseltamivir-treated children.
Topics: Acetamides; Child, Preschool; Female; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Recurrence | 2003 |